Rainbow Rare Earths Phalaborwa project shaping up to be one of the lowest cost producers globally. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,599.00
Bid: 1,594.50
Ask: 1,595.50
Change: -19.00 (-1.17%)
Spread: 1.00 (0.063%)
Open: 1,608.00
High: 1,615.00
Low: 1,575.00
Prev. Close: 1,618.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London open: Stocks surge as markets play catch up after long weekend

Tue, 28th May 2013 08:30

UK markets surged in early trading on Tuesday with traders wasting no time in playing catch up as they returned to their desks following the three-day weekend.After reaching a 13-year high on Wednesday, the FTSE 100 dropped sharply in the latter part of last week on fears of a scaling back of stimulus measures from the US Federal Reserve - after comments from Fed Chairman Ben Bernanke - as well as some gloomy economic data from China.However, Senior Market Analyst Michael Hewson from CMC Markets said that stocks were expected to make up for lost ground today following a fairly quiet but positive European session yesterday.Ahead of the open, Hewson said: "The extra day for UK and US markets is likely to have been useful for investors to weigh up and absorb last week's events, and what they mean going forward for their asset allocation decisions in a world where the prospect of open ended quantitative easing from the US is no longer the done deal investors thought it was a few weeks ago, while a Chinese slowdown remains a growing concern."The economic data calendar is looking pretty light for Tuesday with no major releases due out in Europe this morning, though eyes will be fixed on consumer confidence and home-price figures in the States due out this afternoon.Pharmas gains early onDrugs giant AstraZeneca was among the high risers this morning after saying that it will continue to "vigorously" defend the intellectual property rights protecting its asthma medicine Pulmicort Respules. The company is appealing against a US court ruling that the patent protecting Pulmicort from rival drugs in the US is invalid. Sector peers Shire and GlaxoSmithKline were also in demand early on, with the latter being boosted by an upgrade by Deutsche Bank to 'buy'. The broker also lifted its target price for the shares from 1,620p to 1,930p.Wood Group was also higher on news that its PSN business will continue to provide duty holder and asset management services to the Hummingbird Spirit floating storage offloading production vessel, under a new contract extension worth $87m from Teekay. Positive comments from Bank of America Merrill Lynch were helping share prices of a number of retailers this morning after the broker raised its target prices for Sainsbury, Marks & Spencer, Tesco, Dixons, SuperGroup and Darty.Financial stocks were also performing well as markets on the whole rebounded from last week's sell-off. HSBC, Barclays and Standard Chartered were in positive territory, joined by part-nationalised lenders RBS and Lloyds which were both shrugging off downgrades by Citigroup today.Polymer manufacturer Victrex was a high riser on the FTSE 250 after increasing its interim dividend by 15% and beating profit forecasts by 2.0% in the first half.Soft drinks maker AG Barr was also up as it managed to increase revenues by 2.4% in the first quarter in spite of the dismal weather.FTSE 100 - RisersTUI Travel (TT.) 371.60p +3.65%GKN (GKN) 305.00p +2.90%Hargreaves Lansdown (HL.) 1,017.00p +2.83%International Consolidated Airlines Group SA (CDI) (IAG) 280.50p +2.75%Petrofac Ltd. (PFC) 1,376.00p +2.69%easyJet (EZJ) 1,283.00p +2.64%GlaxoSmithKline (GSK) 1,795.50p +2.63%Barclays (BARC) 325.15p +2.57%IMI (IMI) 1,341.00p +2.44%Weir Group (WEIR) 2,349.00p +2.35%FTSE 100 - FallersEurasian Natural Resources Corp. (ENRC) 249.40p -2.12%Randgold Resources Ltd. (RRS) 4,941.00p -0.94%Rio Tinto (RIO) 2,850.50p -0.58%Glencore Xstrata (GLEN) 330.55p -0.39%Severn Trent (SVT) 2,070.00p -0.05%Anglo American (AAL) 1,556.00p -0.03%FTSE 250 - RisersNew World Resources A Shares (NWR) 114.00p +7.75%Victrex (VCT) 1,739.00p +6.82%Ocado Group (OCDO) 272.70p +3.49%Spirax-Sarco Engineering (SPX) 2,880.00p +3.34%888 Holdings (888) 165.20p +3.12%Mitchells & Butlers (MAB) 396.50p +2.96%Ferrexpo (FXPO) 175.40p +2.93%Berkeley Group Holdings (The) (BKG) 2,183.00p +2.83%Inchcape (INCH) 564.00p +2.73%Pace (PIC) 256.70p +2.68%FTSE 250 - FallersDunelm Group (DNLM) 860.00p -1.15%Carpetright (CPR) 635.00p -1.01%Menzies(John) (MNZS) 711.00p -0.97%Telecom Plus (TEP) 1,275.00p -0.93%TalkTalk Telecom Group (TALK) 228.00p -0.87%Investec (INVP) 480.40p -0.87%Kenmare Resources (KMR) 31.40p -0.82%BH Global Ltd. GBP Shares (BHGG) 1,244.00p -0.64%Ted Baker (TED) 1,481.00p -0.60%John Laing Infrastructure Fund Ltd (JLIF) 113.50p -0.44%
More News
17 Jan 2024 07:46

LONDON BRIEFING: UK inflation surprises as unexpectedly rises to 4.0%

(Alliance News) - Stocks in London are called to open lower on Wednesday, following some hotter-than-expected consumer price data from the UK.

Read more
17 Jan 2024 07:31

GSK raises $1.24 bln from latest Haleon stake sale

Jan 17 (Reuters) - GSK has raised 978 million pounds ($1.24 billion) from a discounted sale of a stake in its spun-off consumer healthcare business Haleon, the British drugmaker said on Wednesday.

Read more
16 Jan 2024 17:04

GSK to sell GBP1 billion worth of Haleon shares as trims stake again

(Alliance News) - GSK PLC on Tuesday said it intends to sell around GBP1.00 billion worth of shares in Haleon PLC, as it continues to reduce its shareholding in the Weybridge, Surrey-based consumer healthcare spin-off.

Read more
16 Jan 2024 09:14

LONDON BROKER RATINGS: UBS raises GSK and cuts AstraZeneca

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
16 Jan 2024 08:15

UBS downgrades AstraZeneca to 'sell'

(Sharecast News) - UBS has downgraded AstraZeneca and upgraded rival GSK as part of its latest review of the European pharmaceutical sector.

Read more
16 Jan 2024 07:37

LONDON BRIEFING: UK jobless rate sticks at 4.2% but pay growth slows

(Alliance News) - Stocks in London are called to open lower on Tuesday, following data showing that the UK jobless rate was unchanged at 4.2% as pay growth slowed.

Read more
15 Jan 2024 08:42

Zantac fallout unfairly weighing on GSK, says Shore Capital

(Sharecast News) - Shore Capital has raised its target price and maintained a positive stance on biopharma giant GSK, saying that worries about the potential cost of Zantac litigation are unfairly weighing on the stock.

Read more
10 Jan 2024 09:35

LONDON BROKER RATINGS: BofA cuts Ashtead; UBS likes 3i Group

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
10 Jan 2024 08:25

GSK says Nucala gets green light in China for asthma treatment

(Alliance News) - GSK PLC on Wednesday said Nucala has been approved in China for the treatment of severe asthma.

Read more
10 Jan 2024 07:22

GSK's Nucala gets fresh approval in China

(Sharecast News) - GSK announced on Wednesday that the China National Medical Products Administration (NMPA) has granted approval for 'Nucala', or mepolizumab, as an add-on maintenance treatment for severe eosinophilic asthma in adults and adolescents aged 12 years and older.

Read more
9 Jan 2024 16:22

London close: Stocks finish red after choppy session

(Sharecast News) - London stocks had turned back into the red by the close on Tuesday, with recruitment firms and asset managers pacing the declines after some disappointing corporate updates.

Read more
9 Jan 2024 08:03

TOP NEWS: GSK to buy Aiolos Bio for up to USD1.4 billion

(Alliance News) - GSK PLC on Tuesday said it will acquire asthma drug developer Aiolos Bio Inc for USD1 billion upfront, as well as up to USD400 million in certain success-based milestone payments.

Read more
9 Jan 2024 07:16

GSK buys respiratory drug maker Aiolos for $1bn

(Sharecast News) - GSK said it was buying Aiolos, a clinical-stage biopharmaceutical company focused on treatment of respiratory and inflammatory conditions, for up to $1.4bn (£1.1bn).

Read more
8 Jan 2024 23:39

Pfizer to remain aggressive on obesity market after setback

NEW YORK, Jan 8 (Reuters) - Pfizer will remain aggressive in trying to break into the lucrative obesity market, even after dropping a high profile weight-loss drug candidate late last year due to strong side effects, Chief Executive Albert Bourla said on Monday.

Read more
8 Jan 2024 23:00

Pfizer to remain aggressive on obesity market after setback

NEW YORK, Jan 8 (Reuters) - Pfizer will remain aggressive in trying to break into the lucrative obesity market, even after dropping a high profile weight-loss drug candidate late last year due to strong side effects, Chief Executive Albert Bourla said on Monday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.